Drug intelligence / Profile preview

canaline

Development stage
Unknown
Modality
Small Molecules
01

Overview

Canaline is a non-proteinogenic amino acid found primarily in legumes such as the jack bean (Canavalia ensiformis). Structurally related to ornithine but distinguished by an aminooxy group in its side chain, canaline acts as an irreversible inhibitor of the mitochondrial enzyme ornithine aminotransferase (OAT), a key enzyme in the urea cycle. By forming a stable oxime with pyridoxal 5′-phosphate at the OAT active site, canaline disrupts normal enzymatic function and interferes with nitrogen metabolism. Its toxicity is attributed both to this inhibition and to its incorporation into proteins via arginyl-tRNA synthetase, resulting in dysfunctional "canavanyl proteins." Canaline also inhibits other pyridoxal-dependent enzymes and can disrupt polyamine metabolism and generate reactive nitrogen species. It plays a role as a plant metabolite involved in chemical defense against insects[1][2][5][6].

Other names
l-canalineo-amino-l-homoserine2-amino-4-(aminooxy)butanoic acidl-homoserine o-amino
02

Targets

OAT (Organic anion transporter family)

Beyond the preview

Go deeper on canaline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on canaline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call